Loading…
Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays
We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor...
Saved in:
Published in: | Journal of pharmaceutical and biomedical analysis 1999-05, Vol.19 (6), p.883-891 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63 |
---|---|
cites | cdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63 |
container_end_page | 891 |
container_issue | 6 |
container_start_page | 883 |
container_title | Journal of pharmaceutical and biomedical analysis |
container_volume | 19 |
creator | Sadick, Michael D Intintoli, Anthony Quarmby, Valerie McCoy, April Canova-Davis, Eleanor Ling, Victor |
description | We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses. |
doi_str_mv | 10.1016/S0731-7085(98)00144-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69441800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708598001447</els_id><sourcerecordid>17252482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</originalsourceid><addsrcrecordid>eNqF0U1rFDEYwPEgFrtWP4KSg0h7mJrM5NWLlKK2tCD4AuIlZJInEJlNxiS70G_vbHfR3noIufzyJPyD0CtKzimh4t03IgfaSaL4qVZnhFDGOvkEraiSQ9cL9vMpWv0jx-h5rb8JIZxq9gwdUyK04pyt0K-bmGwFXMDB3HLB1rW4tS3mhE9vrr9enL3HFhc7R49tWpZzm2IbYDs1KGmBW8AtY0i-m3NMDY8x21rtXX2BjoKdKrw87Cfox6eP3y-vutsvn68vL247x3raOj4EqYnqwWqhuPd-7H0AGIUMzkmuA1dyBLuwEJQDpygnAcbAaZBk8GI4QW_3c-eS_2ygNrOO1cE02QR5U43QjFFFyKOQyp73TPUL5HvoSq61QDBziWtb7gwlZlff3Nc3u7RGK3Nf38jl3OvDBZtxDf7BqX3uBbw5AFudnUKxycX630khlN7N-bBnsGTbRiimugjJgY_LPzXjc3zkJX8Bh2Wh0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17252482</pqid></control><display><type>article</type><title>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Sadick, Michael D ; Intintoli, Anthony ; Quarmby, Valerie ; McCoy, April ; Canova-Davis, Eleanor ; Ling, Victor</creator><creatorcontrib>Sadick, Michael D ; Intintoli, Anthony ; Quarmby, Valerie ; McCoy, April ; Canova-Davis, Eleanor ; Ling, Victor</creatorcontrib><description>We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(98)00144-7</identifier><identifier>PMID: 10698554</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Biological and medical sciences ; Biological Assay - methods ; Enzyme Activation ; Enzyme-Linked Immunosorbent Assay - methods ; General pharmacology ; Humans ; Insulin-Like Growth Factor I - analysis ; Kinase receptor activation (KIRA) ; Ligand bioactivity ; Medical sciences ; Pharmacology. Drug treatments ; Phosphorylation ; Rapid bioassay ; Receptor phosphorylation ; Receptor Protein-Tyrosine Kinases - analysis ; Receptor Protein-Tyrosine Kinases - metabolism ; Receptor, trkA - analysis ; Tumor Cells, Cultured ; Viral Envelope Proteins - analysis</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 1999-05, Vol.19 (6), p.883-891</ispartof><rights>1999 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</citedby><cites>FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1766897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10698554$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sadick, Michael D</creatorcontrib><creatorcontrib>Intintoli, Anthony</creatorcontrib><creatorcontrib>Quarmby, Valerie</creatorcontrib><creatorcontrib>McCoy, April</creatorcontrib><creatorcontrib>Canova-Davis, Eleanor</creatorcontrib><creatorcontrib>Ling, Victor</creatorcontrib><title>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.</description><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>Biological Assay - methods</subject><subject>Enzyme Activation</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor I - analysis</subject><subject>Kinase receptor activation (KIRA)</subject><subject>Ligand bioactivity</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorylation</subject><subject>Rapid bioassay</subject><subject>Receptor phosphorylation</subject><subject>Receptor Protein-Tyrosine Kinases - analysis</subject><subject>Receptor Protein-Tyrosine Kinases - metabolism</subject><subject>Receptor, trkA - analysis</subject><subject>Tumor Cells, Cultured</subject><subject>Viral Envelope Proteins - analysis</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqF0U1rFDEYwPEgFrtWP4KSg0h7mJrM5NWLlKK2tCD4AuIlZJInEJlNxiS70G_vbHfR3noIufzyJPyD0CtKzimh4t03IgfaSaL4qVZnhFDGOvkEraiSQ9cL9vMpWv0jx-h5rb8JIZxq9gwdUyK04pyt0K-bmGwFXMDB3HLB1rW4tS3mhE9vrr9enL3HFhc7R49tWpZzm2IbYDs1KGmBW8AtY0i-m3NMDY8x21rtXX2BjoKdKrw87Cfox6eP3y-vutsvn68vL247x3raOj4EqYnqwWqhuPd-7H0AGIUMzkmuA1dyBLuwEJQDpygnAcbAaZBk8GI4QW_3c-eS_2ygNrOO1cE02QR5U43QjFFFyKOQyp73TPUL5HvoSq61QDBziWtb7gwlZlff3Nc3u7RGK3Nf38jl3OvDBZtxDf7BqX3uBbw5AFudnUKxycX630khlN7N-bBnsGTbRiimugjJgY_LPzXjc3zkJX8Bh2Wh0A</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>Sadick, Michael D</creator><creator>Intintoli, Anthony</creator><creator>Quarmby, Valerie</creator><creator>McCoy, April</creator><creator>Canova-Davis, Eleanor</creator><creator>Ling, Victor</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</title><author>Sadick, Michael D ; Intintoli, Anthony ; Quarmby, Valerie ; McCoy, April ; Canova-Davis, Eleanor ; Ling, Victor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>Biological Assay - methods</topic><topic>Enzyme Activation</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor I - analysis</topic><topic>Kinase receptor activation (KIRA)</topic><topic>Ligand bioactivity</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorylation</topic><topic>Rapid bioassay</topic><topic>Receptor phosphorylation</topic><topic>Receptor Protein-Tyrosine Kinases - analysis</topic><topic>Receptor Protein-Tyrosine Kinases - metabolism</topic><topic>Receptor, trkA - analysis</topic><topic>Tumor Cells, Cultured</topic><topic>Viral Envelope Proteins - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadick, Michael D</creatorcontrib><creatorcontrib>Intintoli, Anthony</creatorcontrib><creatorcontrib>Quarmby, Valerie</creatorcontrib><creatorcontrib>McCoy, April</creatorcontrib><creatorcontrib>Canova-Davis, Eleanor</creatorcontrib><creatorcontrib>Ling, Victor</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadick, Michael D</au><au>Intintoli, Anthony</au><au>Quarmby, Valerie</au><au>McCoy, April</au><au>Canova-Davis, Eleanor</au><au>Ling, Victor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>19</volume><issue>6</issue><spage>883</spage><epage>891</epage><pages>883-891</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>We have developed a novel strategy for a rapid bioassay that is accurate, precise, sensitive, and high capacity. It is capable of quantifying ligand bioactivity by measuring ligand-induced receptor tyrosine kinase activation in terms of receptor phosphorylation. The assay, termed a `kinase receptor activation' or KIRA, utilizes two separate microtiter plates, one for ligand stimulation of intact cells, and the other for receptor capture and phosphotyrosine ELISA. The assay makes use of either endogenously expressed receptors or stably transfected receptors with a polypeptide flag. KIRA assays for the ligands IGF-I and NGF were compared to their corresponding endpoint bioassays (3T3 cell proliferation for IGF-I and PC12 cell survival for NGF). The KIRA assays showed excellent correlation with the more classical endpoint bioassays. Further, they were highly reproducible, minimizing the requirement for repeat assays. The KIRA assay format has great potential as a rapid, accurate and precise bioassay, both for potency determination as well as stability-indicating analyses.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>10698554</pmid><doi>10.1016/S0731-7085(98)00144-7</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0731-7085 |
ispartof | Journal of pharmaceutical and biomedical analysis, 1999-05, Vol.19 (6), p.883-891 |
issn | 0731-7085 1873-264X |
language | eng |
recordid | cdi_proquest_miscellaneous_69441800 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Analysis Biological and medical sciences Biological Assay - methods Enzyme Activation Enzyme-Linked Immunosorbent Assay - methods General pharmacology Humans Insulin-Like Growth Factor I - analysis Kinase receptor activation (KIRA) Ligand bioactivity Medical sciences Pharmacology. Drug treatments Phosphorylation Rapid bioassay Receptor phosphorylation Receptor Protein-Tyrosine Kinases - analysis Receptor Protein-Tyrosine Kinases - metabolism Receptor, trkA - analysis Tumor Cells, Cultured Viral Envelope Proteins - analysis |
title | Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A43%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinase%20receptor%20activation%20(KIRA):%20a%20rapid%20and%20accurate%20alternative%20to%20end-point%20bioassays&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Sadick,%20Michael%20D&rft.date=1999-05-01&rft.volume=19&rft.issue=6&rft.spage=883&rft.epage=891&rft.pages=883-891&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(98)00144-7&rft_dat=%3Cproquest_cross%3E17252482%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-53f79082ea9685dddb2dfeeb67fcc759f587bea53fff8cec8150febf51f703d63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17252482&rft_id=info:pmid/10698554&rfr_iscdi=true |